Hematologic malignancies
Research activity includes acute myeloid leukemia, mantle cell lymphoma, and other B-cell lymphoma settings, with interest in cellular and immunologic treatment strategies.
- CAR-T-cell therapy
- Bispecific antibody combinations
- Targeted treatment in relapsed and frontline disease
Trial activity also extends to transplant-related approaches and treatment selection in biologically high-risk lymphoma.
Hepatology and liver cancer
The sponsor supports studies in hepatocellular carcinoma and chronic hepatitis B, with attention to systemic therapy, immunotherapy, and locoregional liver-directed treatment.
- Non-resectable hepatocellular carcinoma
- Therapeutic hepatitis B vaccination
- TACE and SIRT strategies
Its liver-focused portfolio links antiviral immunology with advanced oncologic management for unresectable disease.
Cardiovascular medicine
Clinical studies address atrial fibrillation with acute coronary syndromes, transcatheter aortic valve replacement, and inflammatory cardiomyopathy with impaired cardiac function.
- Antithrombotic therapy in acute coronary intervention
- Valve replacement peri-procedural management
- Inflammatory cardiomyopathy and heart failure
Additional interest is seen in treatment strategies aimed at preserving cardiac performance and reducing ischemic or bleeding complications.
Gastroenterology, neurology, and immune-mediated disease
The portfolio includes Crohn’s disease, acute ischemic stroke, and acute unilateral vestibulopathy, reflecting work across inflammatory, neurologic, and vestibular disorders.
- Fecal microbiota transplantation
- Inflammation modulation after stroke
- Vestibular symptom management
There is also involvement in schizophrenia research, with emphasis on cognition and functional outcomes.
Thrombosis and immune modulation
Further trials examine symptomatic leg vein thrombosis, immune suppression, and treatment-related inflammation across diverse clinical settings.
- Venous thromboembolism prevention
- Immune response control
- Inflammation-related biomarkers
These studies connect coagulation, vascular risk, and immune pathways in both acute and preventive care contexts.
